We use cookies on this site to enhance your user experience. Do You agree?

Read more

Interdisciplinary Laboratory of Molecular Biology and Biophysics

 


Profile
Leader
Team
Projects
Publications
Contact
Website

Profile

Prof. Edward Darżynkiewicz

The Laboratory’s main field of interest focuses on the so-called cap structures, i.e. the modified nucleotides that decorate the 5’ ends of eukaryotic mRNAs and many snRNAs. Our current activities cover interdisciplinary studies on the molecular mechanisms of interactions between cap structures and protein regulator factors that are involved in processes of protein biosynthesis, RNA degradation and RNA recognition by cellular sensors. Results of our work will allow us to understand the significance of cap structure modifications in coordination of various functional processes that take place throughout the mRNA life cycle.

Furthermore, attempts are made to combine basic research with practical applications in order to design and synthesize mRNA transcripts that are stable and highly active translationally in a cell, which in turn can be used for biotechnological protein production and development of mRNA-based therapies. Our long-term goal is to develop modern mRNA-based drugs for protein replacement therapies or stem cells reprogramming. In our research we use a broad range of chemical, biological and biophysical methodologies. Our team cooperates with several laboratories located both in Poland and abroad.

Leader

We regret to inform you that prof. Edward Darżynkiewicz, outstanding scientist, head of the Interdisciplinary Laboratory of Molecular Biology and Biophysics at the Center for New Technologies at the University of Warsaw, passed away on February 21, 2024.

Edward Darżynkiewicz, after graduating from the 2nd Secondary School in 1965. Adam Mickiewicz in Skarżysko-Kamienna, in 1965-1970 he studied at the Faculty of Chemistry of the University of Warsaw. His interest in issues at the border of chemistry, biology and physics resulted in him completing his master’s thesis at the Department of Biophysics, at the Institute of Experimental Physics, Faculty of Physics, University of Warsaw, under the supervision of Prof. David Shugar. Prof. Shugar was also the supervisor of his doctoral thesis, defended in 1976.

In 1978, Edward Darżynkiewicz went on a long-term postdoctoral fellowship to Aaron Shatkin’s laboratory at the Roche Institute of Molecular Biology in Nutley. In 1975, Aaron Shatkin made the groundbreaking discovery of a unique cap structure at the 5′ end of reovirus mRNA, which had a profound impact on our understanding of mRNA biogenesis. Edward Darżynkiewicz began research of cap. After returning to Poland in 1980, where the opportunities for scientific development were more than modest, Edward Darżynkiewicz decided to continue the research started with Shatkin, and his idea was to chemically modify caps and use modified caps in various types of biological and biophysical research. It was very difficult, given the overwhelming powerlessness in Poland at that time, but the idea turned out to be a “bull’s-eye”. This idea twenty years later made him one of the most recognizable researchers from the University of Warsaw in the world and allowed him to be called one of the most outstanding Polish scientists at the turn of the 20th and 21st centuries. The research he initiated led to the discovery of a way to increase the durability of mRNA, which resulted in one of the largest commercializations of science in Poland. In December 2010, a license agreement was signed with the pharmaceutical company BioNTech AG from Mainz (Germany), covering the exclusive right to use inventions covered by patents entitled “Synthesis and use of anti-reverse phosphorothioate analogs of the messenger RNA cap” and “mRNA Cap Analogs”, in therapeutic applications (development of a new generation of anticancer vaccines based on cell-stable mRNAs). For discoveries related to these patents, Prof. Jacek Jemielity, Prof. Edward Darżynkiewicz, Joanna Kowalska, PhD and a collaborating team of scientists from the University of Warsaw received a nomination for the European Inventor Award in the research category in 2018, for the invention of “messenger RNA with increased stability”.

Professor Edward Darżynkiewicz was the co-author of 192 publications cited over 6,000 times (according to the SCOPUS database), and was awarded the medal. Leon Marchlewski for outstanding achievements in the field of molecular biology and many other awards. He collaborated with the most outstanding mRNA researchers in the world, such as Robert E. Rhoads (Louisiana State University), Ugur Sahin (Johannes Gutenberg University of Mainz), Nahum Sonenberg (McGill University), Stephen Cusack and Iain Mattaj (European Bioinformatics Institute), Thomas Preiss ( Australian National University), Janusz M. Bujnicki (United Way) and Ryszard Kierzek (Polish Academy of Sciences).

Team

Kierownik
Prof. Darżynkiewicz

Senior researcher
Renata Grzela, PhD

Postdocs
Mikołaj Kaźmierczak, PhD
Siranjeevi Nagaraj, PhD

PhD Students
Jingping Geng, MSc

Research technician
Anna Stankiewicz-Drogoń, PhD

Selected projects

Title Leader Years Funding
Designing modified mRNAs as vaccines and therapeutic protein carriers. Studies on their immunogenicity in the context of translational activity and cellular stability E. Darżynkiewicz 2020-2025 NCN OPUS
Exploitation of regenerative potential of mesenchymal stem cells E. Darżynkiewicz 2016-2021 NCBiR STRATEGMED – EXPLORE ME
The influence of intracellular conditions on the state of human decapping enzyme interactome. R. Grzela 2019-2020 NCN MINIATURA

Selected publications

  • Nagaraj S., Stankiewicz-Drogon A., Darzynkiewicz E., Wojda U., Grzela R.
    miR-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levels
    (2024) Scientific Reports, 14 (1), art. no. 4237
    DOI: 10.1038/s41598-024-54154-1
  • Geng J., Chrabaszczewska M., Kurpiejewski K., Stankiewicz-Drogon A., Jankowska-Anyszka M., Darzynkiewicz E., Grzela R.
    Cap-related modifications of RNA regulate binding to IFIT proteins
    (2024) RNA, 30 (10), pp. 1292 – 1305
    DOI:10.1261/rna.080011.124
  • Lukaszewicz M., Ferenc-Mrozek A., Bojarska E., Stelmach J., Stepinski J., Darzynkiewicz E.
    Contribution of Nudt12 enzyme to differentially methylated dinucleotides of 5’RNA cap structure
    (2023) Biochimica et Biophysica Acta – General Subjects, 1867 (9), art. no. 130400
    DOI:10.1016/j.bbagen.2023.130400
  • Andrzejewska A., Grzela R., Stankiewicz-Drogon A., Rogujski P., Nagaraj S., Darzynkiewicz E., Lukomska B., Janowski M.
    Mesenchymal stem cell engineering by ARCA analog-capped mRNA
    (2023) Molecular Therapy Nucleic Acids, 33, pp. 454 – 468
    DOI: 10.1016/j.omtn.2023.07.006
  • Grzela R., Piecyk K., Stankiewicz-Drogon A., Pietrow P., Lukaszewicz M., Kurpiejewski K., Darzynkiewicz E., Jankowska-Anyszka M.
    N2 modified dinucleotide cap analogs as a potent tool for mRNA engineering
    (2023) RNA, 29 (2), pp. 200 – 216
    DOI: 10.1261/rna.079460.122
  • Wojciechowska, M., Macyszyn, J., Miszkiewicz, J., Grzela, R., Trylska, J.
    Stapled anoplin as an antibacterial agent
    (2021) Front. Microbiol., 13 December 2021
    DOI: 10.3389/fmicb.2021.772038
  • Galloway, A., Kaskar, A., Ditsova, D., Atrih, A., Yoshikawa, H., Gomez-Moreira, C., Suska, O., Warmiński, M., Grzela, R., I Lamond, A., Darżynkiewicz, E., Jemielity, J., Cowling, V.H.
    Upregulation of RNA cap methyltransferase RNMT drives ribosome biogenesis during T cell activation.
    (2021) Nucleic Acids Research, 49(12): 6722–6738.
    DOI: 10.1093/nar/gkab465
  • Chrabąszczewska, M., Winiewska-Szajewska, M., Ostrowska, N., Bojarska, E., Stępiński, J., Mancewicz, Ł., Łukaszewicz, M., Trylska, J., Taube, M., Kozak, M., Darżynkiewicz, E., Grzela, R.
    Insight into the Binding and Hydrolytic Preferences of hNudt16 Based on Nucleotide Diphosphate Substrates.
    (2021) International Journal of Molecular Sciences, 22(20):10929
    DOI:10.3390/ijms222010929
  • Miedziak, B., Dobieżyńska, A., Darżynkiewicz, Z. M., Bartkowska, J., Miszkiewicz, J., Kowalska, J., … & Darzynkiewicz, E.
    Kinetic analysis of IFIT1 and IFIT5 interactions with different native and engineered RNAs and its consequences for designing mRNA-based therapeutics

    (2020)RNA, 26(1), 58-68.
    DOI: 10.1261/rna.073304.119
  • Dobieżyńska, A., Miszkiewicz, J., Darżynkiewicz, Z. M., Tyras, M., Stankiewicz-Drogoń, A., Trylska, J., … & Grzela, R.
    Development of bis-ANS-based modified fluorescence titration assay for IFIT/RNA studies
    (2020) Biochemical and Biophysical Research Communications, 533(3), 391-396
    DOI:j.bbrc.2020.09.006

Contact